Committees’ opinions on application for authorisation available
The consolidated opinions of the Committees for Risk Assessment and Socio-Economic Analysis for uses of the following substances are now available:
- two uses of 4-(1,1,3,3-tetramethylbutyl)phenol, ethoxylated by Phadia GmbH, Thermo Fisher Scientific Baltics UAB, and B·R·A·H·M·S GmbH; and
- two uses of 4-nonylphenol, branched and linear, ethoxylated by Phadia GmbH, Thermo Fisher Scientific Baltics UAB, and B·R·A·H·M·S GmbH; and
- one use of nonylphenol, branched, ethoxylated by Safran Landing Systems and SOCIETE DE TRAITEMENTS ELECTROLYTIQUES NORMALISES S.T.E.N.